miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers

被引:59
|
作者
El-Mahdy, Hesham A. [1 ]
Sallam, Al-Aliaa M. [2 ]
Ismail, Ahmed [1 ]
Elkhawaga, Samy Y. [1 ]
Elrebehy, Mahmoud A. [2 ]
Doghish, Ahmed S. [2 ]
机构
[1] Al Azhar Univ, Fac Pharm Boys, Biochem & Mol Biol Dept, Cairo 11231, Egypt
[2] Badr Univ Cairo BUC, Fac Pharm, Dept Biochem, Cairo 11829, Egypt
关键词
Hepatocellular carcinoma (HCC); Oncogenic miRNAs; Tumor Suppressor (TS) miRNAs; Pathogenesis; Drug Resistance; SUPPRESSES CELL-PROLIFERATION; LIVER-CANCER CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; POTENTIAL VEGFR-2 INHIBITORS; INCREASES DRUG-RESISTANCE; WNT/BETA-CATENIN PATHWAY; DELTA T-CELLS; DOWN-REGULATION; SORAFENIB RESISTANCE; TUMOR-GROWTH;
D O I
10.1016/j.prp.2022.153886
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths worldwide. HCC initiation, progression, and therapy failure are all influenced by various variables, including microRNAs (miRNAs). miRNAs are short non-coding RNA sequences that modulate target mRNA expression by deteriorating or repressing translation. miRNAs play an imperative role in HCC pathogenesis by triggering the induction of cancer stem cells (CSCs) and their proliferation, while also delaying apoptosis, sustaining the cell cycle, and inspiring angiogenesis, invasion, and metastasis. Additionally, miRNAs modulate crucial HCC-related molecular pathways such as the p53 pathway, the Wnt/beta-catenin pathway, VEGFR2, and PTEN/PI3K/AKT pathway. Consequently, the goal of this review was to give an up-to-date overview of oncogenic and tumor suppressor (TS) miRNAs, as well as their potential significance in HCC pathogenesis and treatment responses, highlighting their underpinning molecular pathways in HCC initiation and progression. Similarly, the biological importance and clinical application of miRNAs in HCC are summarized.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Hepatocellular carcinoma: Epidemiology and clinical aspects
    Mazzanti, Roberto
    Gramantieri, Laura
    Bolondi, Luigi
    MOLECULAR ASPECTS OF MEDICINE, 2008, 29 (1-2) : 130 - 143
  • [32] CLINICAL ASPECTS OF HEPATOCELLULAR CARCINOMA IN MAN
    DESAI, HN
    SOUTH AFRICAN MEDICAL JOURNAL, 1976, 50 (41): : 1611 - 1613
  • [33] LOXL4 is downregulated in hepatocellular carcinoma with a favorable prognosis
    Tian, Mengxin
    Liu, Weiren
    Jin, Lei
    Jiang, Xifei
    Yang, Liuxiao
    Ding, Zhenbin
    Shen, Yinghao
    Peng, Yuanfei
    Gao, Dongmei
    Li, Lixin
    Zhou, Jian
    Qiu, Shuangjian
    Dai, Zhi
    Fan, Jia
    Shi, Yinghong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (04): : 3892 - 3900
  • [34] Favorable effect of thrombocytopenia on outcomes of liver transplantation for hepatocellular carcinoma
    Liu, Bing
    Liu, Kan
    Teng, Fei
    Fu, Hong
    Guo, Wen-Yuan
    Shi, Xiao-Min
    Ni, Zhi-Jia
    Gao, Xiao-Gang
    Ma, Jun
    Fu, Zhi-Ren
    Ding, Guo-Shan
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (04) : 509 - 510
  • [35] Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
    Farinati, Fabio
    Sergio, Adriana
    Giacomin, Anna
    Di Nolfo, Maria Anna
    Del Poggio, Paolo
    Benvegnu, Luisa
    Rapaccini, Gianludovico
    Zoli, Marco
    Borzio, Franco
    Giannini, Edoardo G.
    Caturelli, Eugenio
    Trevisani, Franco
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (10) : 1212 - 1218
  • [36] Favorable outcomes of surgical resection for extrahepatic recurrent hepatocellular carcinoma
    Midorikawa, Yutaka
    Takayama, Tadatoshi
    Nakayama, Hisashi
    Moriguchi, Masamichi
    Aramaki, Osamu
    Yamazaki, Shintaro
    Teramoto, Kenichi
    Yoshida, Nao
    Kobayashi, Naoya
    Tsuji, Shingo
    Higaki, Tokio
    HEPATOLOGY RESEARCH, 2020, 50 (08) : 978 - 984
  • [37] miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression
    Chu, Rui
    Mo, Guangquan
    Duan, Zhijun
    Huang, Mei
    Chang, Jiuyang
    Li, Xiaodong
    Liu, Pixu
    CELL COMMUNICATION AND SIGNALING, 2014, 12
  • [38] Identification of pyroptosis-associated miRNAs in the immunoscape and prognosis of hepatocellular carcinoma
    Zheng, Yuting
    Huang, Xing
    BMC CANCER, 2024, 24 (01)
  • [39] Identification of the critical genes and miRNAs in hepatocellular carcinoma by integrated bioinformatics analysis
    Wang, Jun
    Wang, Chuyan
    Yang, Liuqing
    Li, Kexin
    MEDICAL ONCOLOGY, 2022, 39 (02)
  • [40] miRNAs: new tools for molecular classification, diagnosis and prognosis of hepatocellular carcinoma
    Liu, Angela M.
    Wang, Wei
    Luk, John M.
    HEPATIC ONCOLOGY, 2014, 1 (03) : 323 - 329